acta medica okayama · 2020. 8. 6. · 2 acta medica okayama, vol. 56 [2002], iss. 1, art. 1

8
Acta Medica Okayama Volume 56, Issue 1 2002 Article 1 F EBRUARY 2002 Catechol-O-methyltransferase and Parkinson’s disease. Chun-Hwi Tai * Ruey-meei Wu * National Taiwan University Hospital, National Taiwan University, Copyright c 1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.

Upload: others

Post on 15-Aug-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

Acta Medica OkayamaVolume 56, Issue 1 2002 Article 1

FEBRUARY 2002

Catechol-O-methyltransferase and Parkinson’sdisease.

Chun-Hwi Tai∗ Ruey-meei Wu†

∗National Taiwan University Hospital,†National Taiwan University,

Copyright c©1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.

Page 2: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

Catechol-O-methyltransferase and Parkinson’sdisease.∗

Chun-Hwi Tai and Ruey-meei Wu

Abstract

Parkinson’s disease (PD) is one of the main causes of neurological disability in the elderly.Levodopa is the gold standard for treating this disease, but chronic levodopa therapy is complicatedby motor fluctuation and dyskinesia. The catechol-O-methyltransferase (COMT) inhibitors rep-resent a new class of antiparkinsonian drugs. When coadministered with levodopa/decarboxylaseinhibitor, 2 COMT inhibitors, tolcapone and entacapone have been shown to improve the clinicalbenefit of levodopa. COMT activity is genetically polymorphic, and individuals with the low activ-ity (COMT(L/L)) genotype have a thermolabile COMT protein; studies suggest that this genotypeis less common in Asians than in Caucasians. Differences in COMT activity may determine theindividual response to levodopa and result in ethnic differences in PD susceptibility. Our recentstudy suggests that the COMTL allele can interact with the MAOB gene to increase the occurrenceof PD in Taiwanese. In order to understand this new class of antiparkinsonian drugs, we reviewtheir basic properties, pharmacology, and clinical efficacy. The frequency distribution of COMTgenetic polymorphisms among different populations and its implications in the etiology and drugresponse is also discussed.

KEYWORDS: parkinson’s disease, catechol-O-methyltransferase, catechol-O-methyltransferaseinhibitors, genetic polymorphism, susceptibility

∗PMID: 11873938 [PubMed - indexed for MEDLINE]Copyright (C) OKAYAMA UNIVERSITY MEDICAL SCHOOL

Page 3: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

1

Tai and Wu: Catechol-O-methyltransferase and Parkinson's disease.

Produced by The Berkeley Electronic Press, 2002

Page 4: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

2

Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

http://escholarship.lib.okayama-u.ac.jp/amo/vol56/iss1/1

Page 5: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

3

Tai and Wu: Catechol-O-methyltransferase and Parkinson's disease.

Produced by The Berkeley Electronic Press, 2002

Page 6: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

4

Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

http://escholarship.lib.okayama-u.ac.jp/amo/vol56/iss1/1

Page 7: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

5

Tai and Wu: Catechol-O-methyltransferase and Parkinson's disease.

Produced by The Berkeley Electronic Press, 2002

Page 8: Acta Medica Okayama · 2020. 8. 6. · 2 Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

6

Acta Medica Okayama, Vol. 56 [2002], Iss. 1, Art. 1

http://escholarship.lib.okayama-u.ac.jp/amo/vol56/iss1/1